FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/11/2024
Voltar para busca
Dado oficial do USPTO
DBV TECHNOLOGIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DBV TECHNOLOGIES
ST13
US500000079364819Classe
5, 10, 41, 42, 44
Pedido
79364819
Registro
7390033
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
10/01/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 41, 42, 44
Data de depósito
19/09/2022
Data de registro
21/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/05/2024
Última transação
10/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
FR
Examinador
MARTIN, LIEF
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
D. T. (pessoa física)
Representantes
Jennifer Sheehan Anderson Bridge Intellectual Property Services PL
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergiesautoimmuneinflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergiesautoimmuneinflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergiesautoimmuneinflammatory and infectious diseases
Classe 10
Medical apparatusinstruments and devicesepicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible mediaepicutaneous patches sold without medication
Classe 41
Educational services for consumers and professionals in the field of immunotherapyorganizing classesseminarsprogramsconferencescongressesworkshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicalsbooksguides in the field of immunotherapy; database publishing servicesnamely publishing of periodical journals containing printed databases in tabular form in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website
Classe 42
Medical and scientific research in the field of immunotherapydeveloping scientific methods for epicutaneous immunotherapyto try to treat and prevent autoimmuneinfectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research servicesdeveloping methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research servicesdeveloping methods for the treatment and prevention of allergiesautoimmuneinfectious and inflammatory diseases by applying patches to patients' unbroken skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact
Classe 44
Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergiesinflammatoryautoimmune and infectious diseases through the administration of allergensantigens using patches affixed to the patients' unbroken skinthus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergiesinflammatoryautoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergiesinflammatoryautoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2024
FIMP
FINAL DISPOSITION PROCESSED
09/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/08/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
13/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
21/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2024
PUBO
PUBLISHED FOR OPPOSITION
05/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/01/2024
RFNT
REFUSAL PROCESSED BY IB
29/08/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/08/2023
RFRR
REFUSAL PROCESSED BY MPU
09/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/07/2023
CNRT
NON-FINAL ACTION WRITTEN
04/07/2023
DOCK
ASSIGNED TO EXAMINER
29/06/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DBV TECHNOLOGIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.